Using specific pharmacological inhibitors and siRNAs to investigate the potential role of individual MAPKs in docetaxel-induced PHD1 activation in hypoxic cancer cells, we found that the JNK inhibitor SP600125 reduced PHD1 phosphorylation and restored HIF-1α accumulation (Fig. 4b,c). The gene discussed is MAPK8; the disease is cancer.